Dhunseri Ventures Limited (DPL.BO)
ValueMarkers Composite Index
DCF data not available
Dhunseri Ventures Limited (DPL.BO) — VMCI valuation read
Composite valuation read on DPL.BO: VMCI 56/100 against a Basic Materials sector median of 50. The 6-point above-median print is the headline number for Dhunseri Ventures Limited, and at the mid-cap tier it reflects how the five pillars combine into a single decision-grade score.
Trailing 30-day insider activity for DPL.BO: nothing material on SEC EDGAR. With the Form 4 channel quiet, the price-vs-DCF gap and the trailing margin trend carry more weight in the active read.
**Investor frame.** Value, quality, risk in three lines on DPL.BO: DPL.BO trades at 21.0x earnings, 17% above the Basic Materials median of 18.0x; ROIC of 9.0% trails the Basic Materials median (10.0%) by 1.0pp; net debt to EBITDA of -0.5x leaves covenant headroom. EV/EBITDA at 14.0x versus 12.0x for Basic Materials closes the value frame.
DPL.BO fell 3.1% over the trailing 7 days, with a +1.4% read on a 30-day basis.
Dipna Pharmachem Ltd. engages in the trading and distribution of pharmaceutical raw material and chemical formulation products. Its raw material includes active pharmaceutical ingredients and excipient chemical formulation products. It also sells chemicals on commission basis. The company was founded on July 19, 2011 and is headquartered in Ahmedabad, India.
Related Stocks in Basic Materials
Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.